Skip to content
Home/Companies/MedTech/Pixium Vision

Pixium Vision

MedTech·France·Exited 2024·Held 11yr
Entry
2013
Hold
11yr
Exit
2024

Who owns Pixium Vision?

Pixium Vision is a French MedTech company, now owned by Science, which acquired it in 2024 from Sofinnova Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Most recent investor
Sofinnova Partners
Sofinnova Capital VII · 2012 · Life Sciences VC
2 ownership periods · full history below

Key facts

HQFrance
SectorMedTech
Key takeaways
  • ·Fully exited in 2024 to Science Corporation.
  • ·Average hold across 2 realized cycles: 7 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2024 to Science Corporation.
Co-invest · 2 holders · 2011 · 2024
Ibionext
IbionextExited 2014
2011 · 2014(3yr) · iBionext Growth Fund · 2018 · VC
IPO

Ibionext took Pixium Vision public via IPO in 2014 after 3 years.

Sofinnova Partners
2013 · 2024(11yr) · Sofinnova Capital VII · 2012 · Life Sciences VC
Trade Sale · to Science Corporation

Sofinnova Partners sold Pixium Vision to Science in 2024 after 11 years.

Questions

Who owns Pixium Vision?

Pixium Vision is now owned by Science, which acquired it in 2024 from Sofinnova Partners.

When did Science acquire Pixium Vision?

Science acquired Pixium Vision in 2024, buying from Sofinnova Partners.

Who did Pixium Vision sell to?

Sofinnova Partners sold Pixium Vision to Science in 2024 (Trade Sale).

Who has owned Pixium Vision over time?

Pixium Vision has been through 2 private-equity ownership periods: Ibionext · via iBionext Growth Fund · 2011–2014 · (IPO); Sofinnova Partners · via Sofinnova Capital VII · 2013–2024 · sold to Science · (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue